Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
To establish a Framework Agreement with the following Blood Establishments as beneficiaries - NHS Blood and Transplant; the Welsh Blood Service (WBS); the Northern Ireland Blood Transfusion Service (NIBTS); the Scottish National Blood Transfusion Service (SNBTS); the Australian Red Cross Lifeblood (ARCL), the New Zealand Blood Service (NZBS) and the Irish Blood Transfusion Service
(IBTS).
Additive Solutions for the Suspension of Blood Products:
Lot 1: Additive solution for the suspension of pooled platelets, granulocytes and other components derived from whole blood; Additive solution for the suspension of single donor apheresis derived platelets;
Lot 2: SAGM solution for the routine washing and re-suspension of red cells during the production of specialist blood components in accordance with the Guidelines for the Blood Transfusion Services in the UK details of which can be found at the following website https://www.transfusionguidelines.org/red-book
Lot 3: Additive Solution for the suspension of washed platelets;
Lot 4: Saline 0.9% for the dilution of serum eye drops
Additional information:
To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.
Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:
Phone: 0800 9956035
E-mail: …@atamis.co.uk
No supplier information available.